1 | DUPILUMAB (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬 | [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [5] 51 51, 97, 98, 160, 162 💬 |
2 | Dupilumab (blinded) (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬 | [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 98 98 💬 |
3 | Dupilumab (open-label) (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬 | [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 98 98 💬 |
4 | Dupilumab 300Mg Solution for Injection (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬 | [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 51 51 💬 |
5 | Dupilumab Injection (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬 | [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬 |
6 | Dupilumab Prefilled Syringe (D10354) | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
(D10354) 💬 | [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬 |